Answers are grounded in this paper and cite their sources.
The novel tyrosine kinase inhibitor AKN028 has demonstrated promising results in preclinical trials. An expedient protocol for the synthesis of the compound at kilogram scale is described, including an S N Ar reaction with high regioselectivity and a Suzuki coupling. Furthermore, an efficient method for purification and removal of residual palladium is described.
No takes yet. Share an insight, caveat, or question.
Bremberg et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: